Where Does Vincerx Pharma Inc (VINC) Stock Fall in the Biotechnology Field After It Has Fallen -8.07% This Week?

Vincerx Pharma Inc (VINC) is around the top of the Biotechnology industry according to InvestorsObserver. VINC received an overall rating of 77, which means that it scores higher than 77 percent of all stocks. Vincerx Pharma Inc also achieved a score of 91 in the Biotechnology industry, putting it above 91 percent of Biotechnology stocks. Biotechnology is ranked 19 out of the 148 industries.

VINC has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on VINC!

See Full VINC Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 77 means the stock is more attractive than 77 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Vincerx Pharma Inc Stock Today?

Vincerx Pharma Inc (VINC) stock is down -17.33% while the S&P 500 has gained 0.11% as of 2:10 PM on Thursday, Mar 28. VINC is down -$1.05 from the previous closing price of $6.06 on volume of 438,196 shares. Over the past year the S&P 500 has risen 30.45% while VINC has gained 391.18%. VINC lost -$2.30 per share the over the last 12 months. Click Here to get the full Stock Report for Vincerx Pharma Inc stock.